Loading...

Craig McDonald

TitleDEPARTMENT CHAIR
InstitutionUniversity of California Davis
DepartmentMED: PHYS MED & REHAB
AddressACC/UCDMC
CA 95817
Phone916-734-2923
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Shieh PB, McIntosh J, Jin F, Souza M, Elfring G, Narayanan S, Trifillis P, Peltz SW, McDonald C, Darras BT. Deflazacort vs prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post hoc analysis from the ACT DMD trial. Muscle Nerve. 2018 Jul 20. PMID: 30028519.
      View in: PubMed
    2. McDonald C, Mercuri E. Evidence-based care in Duchenne muscular dystrophy. Lancet Neurol. 2018 May; 17(5):389-391. PMID: 29656735.
      View in: PubMed
    3. Mah JK, Feng J, Jacobs MB, Duong T, Carroll K, de Valle K, Carty CL, Morgenroth LP, Guglieri M, Ryan MM, Clemens PR, Thangarajh M, Webster R, Smith E, Connolly AM, McDonald C, Karachunski P, Tulinius M, Harper A, Cnaan A, Chen YW. A multinational study on motor function in early-onset FSHD. Neurology. 2018 Apr 10; 90(15):e1333-e1338. PMID: 29540582.
      View in: PubMed
    4. Oskarsson B, Moore D, Mozaffar T, Ravits J, Wiedau-Pazos M, Parziale N, Joyce NC, Mandeville R, Goyal N, Cudkowicz ME, Weiss M, Miller RG, McDonald C. Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial. Muscle Nerve. 2018 Mar 06. PMID: 29510461.
      View in: PubMed
    5. Maselli RA, Arredondo J, Vázquez J, Chong JX, Bamshad MJ, Nickerson DA, Lara M, Ng F, Lo VL, Pytel P, McDonald C. A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5. Ann N Y Acad Sci. 2018 Feb; 1413(1):119-125. PMID: 29377152.
      View in: PubMed
    6. Goemans N, Mercuri E, Belousova E, Komaki H, Dubrovsky A, McDonald C, Kraus JE, Lourbakos A, Lin Z, Campion G, Wang SX, Campbell C. A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Jan; 28(1):4-15. PMID: 29203355.
      View in: PubMed
    7. McDonald C, Henricson EK, Abresch RT, Duong T, Joyce NC, Hu F, Clemens PR, Hoffman EP, Cnaan A, Gordish-Dressman H. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet. 2018 02 03; 391(10119):451-461. PMID: 29174484.
      View in: PubMed
    8. Victor RG, Sweeney HL, Finkel R, McDonald C, Byrne B, Eagle M, Goemans N, Vandenborne K, Dubrovsky AL, Topaloglu H, Miceli MC, Furlong P, Landry J, Elashoff R, Cox D. A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy. Neurology. 2017 Oct 24; 89(17):1811-1820. PMID: 28972192.
      View in: PubMed
    9. Finder J, Mayer OH, Sheehan D, Sawnani H, Abresch RT, Benditt J, Birnkrant DJ, Duong T, Henricson E, Kinnett K, McDonald C, Connolly AM. Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary. Am J Respir Crit Care Med. 2017 Aug 15; 196(4):512-519. PMID: 28636407.
      View in: PubMed
    10. Fowler EG, Staudt LA, Heberer KR, Sienko SE, Buckon CE, Bagley AM, Sussman MD, McDonald C. Longitudinal community walking activity in Duchenne muscular dystrophy. Muscle Nerve. 2018 Mar; 57(3):401-406. PMID: 28692198.
      View in: PubMed
    11. McDonald C, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F, Osorio AN, Schara U, Sejersen T, Shieh PB, Sweeney HL, Topaloglu H, Tulinius M, Vilchez JJ, Voit T, Wong B, Elfring G, Kroger H, Luo X, McIntosh J, Ong T, Riebling P, Souza M, Spiegel RJ, Peltz SW, Mercuri E. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017 Sep 23; 390(10101):1489-1498. PMID: 28728956.
      View in: PubMed
    12. Thayer S, Bell C, McDonald C. The Direct Cost of Managing a Rare Disease: Assessing Medical and Pharmacy Costs Associated with Duchenne Muscular Dystrophy in the United States. J Manag Care Spec Pharm. 2017 Jun; 23(6):633-641. PMID: 28530521.
      View in: PubMed
    13. Maselli RA, Arredondo J, Vázquez J, Chong JX, Bamshad MJ, Nickerson DA, Lara M, Ng F, Lo VL, Pytel P, McDonald C. Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission. Am J Med Genet A. 2017 Aug; 173(8):2240-2245. PMID: 28544784.
      View in: PubMed
    14. Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, Shieh PB, Straub V, Childs AM, Ciafaloni E, Butterfield RJ, Horrocks I, Spinty S, Flanigan KM, Kuntz NL, Baranello G, Roper H, Morrison L, Mah JK, Manzur AY, McDonald C, Schara U, von der Hagen M, Barohn RJ, Campbell C, Darras BT, Finkel RS, Vita G, Hughes I, Mongini T, Pegoraro E, Wicklund M, Wilichowski E, Bryan Burnette W, Howard JF, McMillan HJ, Thangarajh M, Griggs RC. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy. Contemp Clin Trials. 2017 07; 58:34-39. PMID: 28450193.
      View in: PubMed
    15. Carter GT, McDonald C. William M. Fowler, Jr, MD, 1926-2017. PM R. 2017 May; 9(5):540-541. PMID: 28347900.
      View in: PubMed
    16. Larkindale J, Abresch R, Aviles E, Bronson A, Chin J, Furlong P, Gordish-Dressman H, Habeeb-Louks E, Henricson E, Kroger H, Lynn C, Lynn S, Martin D, Nuckolls G, Rooney W, Romero K, Sweeney L, Vandenborne K, Walter G, Wolff J, Wong B, McDonald C, Duchenne Regulatory Science Consortium Imaging-Dmd Consortium And The Cinrg Investigators MO. Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy. PLoS Curr. 2017 Jan 12; 9. PMID: 28228973.
      View in: PubMed
    17. Bello L, Flanigan KM, Weiss RB, Spitali P, Aartsma-Rus A, Muntoni F, Zaharieva I, Ferlini A, Mercuri E, Tuffery-Giraud S, Claustres M, Straub V, Lochmüller H, Barp A, Vianello S, Pegoraro E, Punetha J, Gordish-Dressman H, Giri M, McDonald C, Hoffman EP. Association Study of Exon Variants in the NF-?B and TGFß Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy. Am J Hum Genet. 2016 Nov 03; 99(5):1163-1171. PMID: 27745838.
      View in: PubMed
    18. Buyse GM, Voit T, Schara U, Straathof CS, D'Angelo MG, Bernert G, Cuisset JM, Finkel RS, Goemans N, Rummey C, Leinonen M, Mayer OH, Spagnolo P, Meier T, McDonald C. Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy. Pediatr Pulmonol. 2017 Apr; 52(4):508-515. PMID: 27571420.
      View in: PubMed
    19. Buckon C, Sienko S, Bagley A, Sison-Williamson M, Fowler E, Staudt L, Heberer K, McDonald C, Sussman M. Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy? PLoS Curr. 2016 Jul 08; 8. PMID: 27500011; PMCID: PMC4956479.
    20. Bello L, Morgenroth LP, Gordish-Dressman H, Hoffman EP, McDonald C, Cirak S. DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study. Neurology. 2016 Jul 26; 87(4):401-9. PMID: 27343068; PMCID: PMC4977110 [Available on 07/26/17].
    21. Sienko S, Buckon C, Fowler E, Bagley A, Staudt L, Sison-Williamson M, Zebracki K, McDonald C, Sussman M. Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life? PLoS Curr. 2016 Jun 17; 8. PMID: 27525172; PMCID: PMC4972246.
    22. Heberer K, Fowler E, Staudt L, Sienko S, Buckon CE, Bagley A, Sison-Williamson M, McDonald C, Sussman MD. Hip kinetics during gait are clinically meaningful outcomes in young boys with Duchenne muscular dystrophy. Gait Posture. 2016 07; 48:159-164. PMID: 27267770.
      View in: PubMed
    23. McDonald C, Meier T, Voit T, Schara U, Straathof CS, D'Angelo MG, Bernert G, Cuisset JM, Finkel RS, Goemans N, Rummey C, Leinonen M, Spagnolo P, Buyse GM. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy. Neuromuscul Disord. 2016 08; 26(8):473-80. PMID: 27238057.
      View in: PubMed
    24. Connolly AM, Florence JM, Zaidman CM, Golumbek PT, Mendell JR, Flanigan KM, Karachunski PI, Day JW, McDonald C, Darras BT, Kang PB, Siener CA, Gadeken RK, Anand P, Schierbecker JR, Malkus EC, Lowes LP, Alfano LN, Johnson L, Nicorici A, Kelecic JM, Quigley J, Pasternak AE, Miller JP. Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up. Muscle Nerve. 2016 10; 54(4):681-9. PMID: 26930423.
      View in: PubMed
    25. Han JJ, de Bie E, Nicorici A, Abresch RT, Anthonisen C, Bajcsy R, Kurillo G, Mcdonald CM. Reachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy. Muscle Nerve. 2016 Apr; 53(4):545-54. PMID: 26342193; PMCID: PMC4779432 [Available on 04/01/17].
    26. Bello L, Gordish-Dressman H, Morgenroth LP, Henricson EK, Duong T, Hoffman EP, Cnaan A, McDonald C. Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study. Neurology. 2015 Sep 22; 85(12):1048-55. PMID: 26311750; PMCID: PMC4603595 [Available on 09/22/16].
    27. Spurney CF, McCaffrey FM, Cnaan A, Morgenroth LP, Ghelani SJ, Gordish-Dressman H, Arrieta A, Connolly AM, Lotze TE, McDonald C, Leshner RT, Clemens PR. Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies. J Am Soc Echocardiogr. 2015 Aug; 28(8):999-1008. PMID: 25906753; PMCID: PMC4526320.
    28. Buyse GM, Voit T, Schara U, Straathof CSM, D'Angelo MG, Bernert G, Cuisset JM, Finkel RS, Goemans N, McDonald C, Rummey C, Meier T. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial. Lancet. 2015 May 02; 385(9979):1748-1757. PMID: 25907158.
      View in: PubMed
    29. Bello L, Kesari A, Gordish-Dressman H, Cnaan A, Morgenroth LP, Punetha J, Duong T, Henricson EK, Pegoraro E, McDonald C, Hoffman EP. Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study. Ann Neurol. 2015 Apr; 77(4):684-96. PMID: 25641372; PMCID: PMC4403971.
    30. Connolly AM, Malkus EC, Mendell JR, Flanigan KM, Miller JP, Schierbecker JR, Siener CA, Golumbek PT, Zaidman CM, Mcdonald CM, Johnson L, Nicorici A, Karachunski PI, Day JW, Kelecic JM, Lowes LP, Alfano LN, Darras BT, Kang PB, Quigley J, Pasternak AE, Florence JM. Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy. Muscle Nerve. 2015 Apr; 51(4):522-32. PMID: 25056178; PMCID: PMC4305351.
    31. Skalsky AJ, Lesser DJ, McDonald C. Evaluation of phrenic nerve and diaphragm function with peripheral nerve stimulation and M-mode ultrasonography in potential pediatric phrenic nerve or diaphragm pacing candidates. Phys Med Rehabil Clin N Am. 2015 Feb; 26(1):133-43. PMID: 25479785.
      View in: PubMed
    32. Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, Connolly AM, Day JW, Flanigan KM, Goemans N, Jones KJ, Mercuri E, Quinlivan R, Renfroe JB, Russman B, Ryan MM, Tulinius M, Voit T, Moore SA, Lee Sweeney H, Abresch RT, Coleman KL, Eagle M, Florence J, Gappmaier E, Glanzman AM, Henricson E, Barth J, Elfring GL, Reha A, Spiegel RJ, O'donnell MW, Peltz SW, Mcdonald CM. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve. 2014 Oct; 50(4):477-87. PMID: 25042182; PMCID: PMC4241581.
    33. Connolly AM, Florence JM, Cradock MM, Eagle M, Flanigan KM, McDonald C, Karachunski PI, Darras BT, Bushby K, Malkus EC, Golumbek PT, Zaidman CM, Miller JP, Mendell JR. One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development. Pediatr Neurol. 2014 Jun; 50(6):557-63. PMID: 24842254; PMCID: PMC4197452.
    34. Allen HD, Flanigan KM, Thrush PT, Dvorchik I, Yin H, Canter C, Connolly AM, Parrish M, McDonald C, Braunlin E, Colan SD, Day J, Darras B, Mendell JR. A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy. PLoS Curr. 2013 Dec 12; 5. PMID: 24459612; PMCID: PMC3871420.
    35. Bodor M, McDonald C. Why short stature is beneficial in Duchenne muscular dystrophy. Muscle Nerve. 2013 Sep; 48(3):336-42. PMID: 23893308.
      View in: PubMed
    36. McDonald C, Henricson EK, Abresch RT, Florence J, Eagle M, Gappmaier E, Glanzman AM, Spiegel R, Barth J, Elfring G, Reha A, Peltz SW. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013 Sep; 48(3):357-68. PMID: 23674289; PMCID: PMC3826053.
    37. Henricson E, Abresch R, Han JJ, Nicorici A, Goude Keller E, de Bie E, McDonald C. The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year. PLoS Curr. 2013 Jul 08; 5. PMID: 23867975.
      View in: PubMed
    38. McDonald C, Henricson EK, Abresch RT, Florence JM, Eagle M, Gappmaier E, Glanzman AM, Spiegel R, Barth J, Elfring G, Reha A, Peltz S. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve. 2013 Sep; 48(3):343-56. PMID: 23681930; PMCID: PMC3824082.
    39. Connolly AM, Florence JM, Cradock MM, Malkus EC, Schierbecker JR, Siener CA, Wulf CO, Anand P, Golumbek PT, Zaidman CM, Philip Miller J, Lowes LP, Alfano LN, Viollet-Callendret L, Flanigan KM, Mendell JR, McDonald C, Goude E, Johnson L, Nicorici A, Karachunski PI, Day JW, Dalton JC, Farber JM, Buser KK, Darras BT, Kang PB, Riley SO, Shriber E, Parad R, Bushby K, Eagle M. Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network. Neuromuscul Disord. 2013 Jul; 23(7):529-39. PMID: 23726376; PMCID: PMC3743677.
    40. McDonald C, Henricson EK, Abresch RT, Han JJ, Escolar DM, Florence JM, Duong T, Arrieta A, Clemens PR, Hoffman EP, Cnaan A. The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle Nerve. 2013 Jul; 48(1):32-54. PMID: 23677550; PMCID: PMC4147958.
    41. Henricson EK, Abresch RT, Cnaan A, Hu F, Duong T, Arrieta A, Han J, Escolar DM, Florence JM, Clemens PR, Hoffman EP, McDonald C. The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Muscle Nerve. 2013 Jul; 48(1):55-67. PMID: 23649481; PMCID: PMC4103170.
    42. Johnston TE, McDonald C. Health and fitness in pediatric spinal cord injury: medical issues and the role of exercise. J Pediatr Rehabil Med. 2013; 6(1):35-44. PMID: 23481890.
      View in: PubMed
    43. Lin W, Pierce A, Skalsky AJ, McDonald C. Mobility-assistive technology in progressive neuromuscular disease. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):885-94. PMID: 23137743.
      View in: PubMed
    44. Maitra S, Roberto RF, McDonald C, Gupta MC. Treatment of spine deformity in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):869-83. PMID: 23137742.
      View in: PubMed
    45. Wolfe LF, Joyce NC, McDonald C, Benditt JO, Finder J. Management of pulmonary complications in neuromuscular disease. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):829-53. PMID: 23137740.
      View in: PubMed
    46. McDonald C, Joyce NC. Neuromuscular disease management and rehabilitation, part II: specialty care and therapeutics. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):xiii-xvii. PMID: 23137747.
      View in: PubMed
    47. McDonald C, Joyce NC. Neuromuscular disease management and rehabilitation, part I: diagnostic and therapy issues. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):xvii-xx. PMID: 22938886.
      View in: PubMed
    48. Abresch RT, Carter GT, Han JJ, McDonald C. Exercise in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):653-73. PMID: 22938880.
      View in: PubMed
    49. McDonald C. Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):495-563. PMID: 22938875; PMCID: PMC3482409.
    50. Skalsky AJ, McDonald C. Prevention and management of limb contractures in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):675-87. PMID: 22938881; PMCID: PMC3482407.
    51. McDonald C, Fowler WM. The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):475-93. PMID: 22938874; PMCID: PMC3482408.
    52. McDonald C. William M. Fowler, Jr., MD. Dedication. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):xxi-xxii. PMID: 22938887.
      View in: PubMed
    53. McDonald C, Han JJ, Mah JK, Carter GT. Corticosteroids and Duchenne muscular dystrophy: does earlier treatment really matter? Muscle Nerve. 2012 Jun; 45(6):777-9. PMID: 22581529.
      View in: PubMed
    54. Henricson E, Abresch R, Han JJ, Nicorici A, Goude Keller E, Elfring G, Reha A, Barth J, McDonald C. Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences. PLoS Curr. 2012 Jan 25; 4:RRN1297. PMID: 22306689; PMCID: PMC3269886.
    55. Skalsky AJ, Han JJ, Abresch RT, McDonald C. Regional and whole-body dual-energy X-ray absorptiometry to guide treatment and monitor disease progression in neuromuscular disease. Phys Med Rehabil Clin N Am. 2012 Feb; 23(1):67-73, x. PMID: 22239875.
      View in: PubMed
    56. Lai JS, Nowinski C, Victorson D, Bode R, Podrabsky T, McKinney N, Straube D, Holmes GL, McDonald C, Henricson E, Abresch RT, Moy CS, Cella D. Quality-of-life measures in children with neurological conditions: pediatric Neuro-QOL. Neurorehabil Neural Repair. 2012 Jan; 26(1):36-47. PMID: 21788436.
      View in: PubMed
    57. McDonald C, Henricson EK, Han JJ, Abresch RT, Nicorici A, Atkinson L, Elfring GL, Reha A, Miller LL. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve. 2010 Dec; 42(6):966-74. PMID: 21038378.
      View in: PubMed
    58. Sienko Thomas S, Buckon CE, Nicorici A, Bagley A, McDonald C, Sussman MD. Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function. J Child Neurol. 2010 Sep; 25(9):1103-9. PMID: 20587736; PMCID: PMC3794706.
    59. McDonald C, McDonald DA, Bagley A, Sienko Thomas S, Buckon CE, Henricson E, Nicorici A, Sussman MD. Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy. J Child Neurol. 2010 Sep; 25(9):1130-44. PMID: 20558672; PMCID: PMC3695468.
    60. McDonald C, Henricson EK, Han JJ, Abresch RT, Nicorici A, Elfring GL, Atkinson L, Reha A, Hirawat S, Miller LL. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve. 2010 Apr; 41(4):500-10. PMID: 19941337.
      View in: PubMed
    61. Abresch RT, Carter GT, Han JJ, McDonald C. New clinical end points in rehabilitation medicine: tools for measuring quality of life. Am J Hosp Palliat Care. 2009 Dec-2010 Jan; 26(6):483-92. PMID: 19923631.
      View in: PubMed
    62. Calhoun CL, Haley SM, Riley A, Vogel LC, McDonald C, Mulcahey MJ. Development of items designed to evaluate activity performance and participation in children and adolescents with spinal cord injury. Int J Pediatr. 2009; 2009:854904. PMID: 20049343; PMCID: PMC2798099.
    63. Miró J, Raichle KA, Carter GT, O'Brien SA, Abresch RT, McDonald C, Jensen MP. Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy. Am J Hosp Palliat Care. 2009 Aug-Sep; 26(4):308-19. PMID: 19414560; PMCID: PMC2845314.
    64. Skalsky AJ, Han JJ, Abresch RT, Shin CS, McDonald C. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Muscle Nerve. 2009 May; 39(5):647-51. PMID: 19347922.
      View in: PubMed
    65. Chen Y, Anderson CJ, Vogel LC, Chlan KM, Betz RR, McDonald C. Change in life satisfaction of adults with pediatric-onset spinal cord injury. Arch Phys Med Rehabil. 2008 Dec; 89(12):2285-92. PMID: 19061740.
      View in: PubMed
    66. Carter GT, Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, McDonald C. Pain in myotonic muscular dystrophy, type 1. Arch Phys Med Rehabil. 2008 Dec; 89(12):2382. PMID: 19061752.
      View in: PubMed
    67. Stoelb BL, Carter GT, Abresch RT, Purekal S, McDonald C, Jensen MP. Pain in persons with postpolio syndrome: frequency, intensity, and impact. Arch Phys Med Rehabil. 2008 Oct; 89(10):1933-40. PMID: 18929021; PMCID: PMC2651567.
    68. Werner BC, Skalsky AJ, McDonald C, Han JJ. Convexity of scoliosis related to handedness in identical twin boys with Duchenne's muscular dystrophy: a case report. Arch Phys Med Rehabil. 2008 Oct; 89(10):2021-4. PMID: 18929032.
      View in: PubMed
    69. Skalsky AJ, Abresch RT, Han JJ, Shin CS, McDonald C. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord. 2008 Nov; 18(11):873-80. PMID: 18818077.
      View in: PubMed
    70. Han JJ, McDonald C. Diagnosis and clinical management of spinal muscular atrophy. Phys Med Rehabil Clin N Am. 2008 Aug; 19(3):661-80, xii. PMID: 18625423.
      View in: PubMed
    71. Hunter LN, Sison-Williamson M, Mendoza MM, McDonald C, Molitor F, Mulcahey MJ, Betz RR, Vogel LC, Bagley A. The validity of compliance monitors to assess wearing time of thoracic-lumbar-sacral orthoses in children with spinal cord injury. Spine (Phila Pa 1976). 2008 Jun 15; 33(14):1554-61. PMID: 18552670.
      View in: PubMed
    72. Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald C. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil. 2008 Feb; 89(2):320-8. PMID: 18226657; PMCID: PMC2828945.
    73. Gupta MC, Wijesekera S, Sossan A, Martin L, Vogel LC, Boakes JL, Lerman JA, McDonald C, Betz RR. Reliability of radiographic parameters in neuromuscular scoliosis. Spine (Phila Pa 1976). 2007 Mar 15; 32(6):691-5. PMID: 17413476.
      View in: PubMed
    74. Hunter L, Molitor F, Chafetz RS, Mulcahey MJ, Vogel LC, Betz RR, McDonald C. Development and pilot test of the shriners pediatric instrument for neuromuscular scoliosis (SPNS): a quality of life questionnaire for children with spinal cord injuries. J Spinal Cord Med. 2007; 30 Suppl 1:S150-7. PMID: 17874701; PMCID: PMC2031972.
    75. Sison-Williamson M, Bagley A, Hongo A, Vogel LC, Mulcahey MJ, Betz RR, McDonald C. Effect of thoracolumbosacral orthoses on reachable workspace volumes in children with spinal cord injury. J Spinal Cord Med. 2007; 30 Suppl 1:S184-91. PMID: 17874706; PMCID: PMC2031977.
    76. McDonald C, Abresch-Meyer AL, Nelson MD, Widman LM. Body mass index and body composition measures by dual x-ray absorptiometry in patients aged 10 to 21 years with spinal cord injury. J Spinal Cord Med. 2007; 30 Suppl 1:S97-104. PMID: 17874694; PMCID: PMC2031982.
    77. Nelson MD, Widman LM, Abresch RT, Stanhope K, Havel PJ, Styne DM, McDonald C. Metabolic syndrome in adolescents with spinal cord dysfunction. J Spinal Cord Med. 2007; 30 Suppl 1:S127-39. PMID: 17874698; PMCID: PMC2031992.
    78. Liusuwan RA, Widman LM, Abresch RT, Styne DM, McDonald C. Body composition and resting energy expenditure in patients aged 11 to 21 years with spinal cord dysfunction compared to controls: comparisons and relationships among the groups. J Spinal Cord Med. 2007; 30 Suppl 1:S105-11. PMID: 17874695; PMCID: PMC2031969.
    79. Liusuwan RA, Widman LM, Abresch RT, Johnson AJ, McDonald C. Behavioral intervention, exercise, and nutrition education to improve health and fitness (BENEfit) in adolescents with mobility impairment due to spinal cord dysfunction. J Spinal Cord Med. 2007; 30 Suppl 1:S119-26. PMID: 17874697; PMCID: PMC2031996.
    80. Chafetz RS, Mulcahey MJ, Betz RR, Anderson C, Vogel LC, Gaughan JP, Odel MA, Flanagan A, McDonald C. Impact of prophylactic thoracolumbosacral orthosis bracing on functional activities and activities of daily living in the pediatric spinal cord injury population. J Spinal Cord Med. 2007; 30 Suppl 1:S178-83. PMID: 17874705; PMCID: PMC2031986.
    81. Anderson CJ, Vogel LC, Chlan KM, Betz RR, McDonald C. Depression in adults who sustained spinal cord injuries as children or adolescents. J Spinal Cord Med. 2007; 30 Suppl 1:S76-82. PMID: 17874691; PMCID: PMC2031993.
    82. Mendell JR, Csimma C, McDonald C, Escolar DM, Janis S, Porter JD, Hesterlee SE, Howell RR. Challenges in drug development for muscle disease: a stakeholders' meeting. Muscle Nerve. 2007 Jan; 35(1):8-16. PMID: 17068768.
      View in: PubMed
    83. Widman LM, Abresch RT, Styne DM, McDonald C. Aerobic fitness and upper extremity strength in patients aged 11 to 21 years with spinal cord dysfunction as compared to ideal weight and overweight controls. J Spinal Cord Med. 2007; 30 Suppl 1:S88-96. PMID: 17874693; PMCID: PMC2031980.
    84. Widman LM, McDonald C, Abresch RT. Effectiveness of an upper extremity exercise device integrated with computer gaming for aerobic training in adolescents with spinal cord dysfunction. J Spinal Cord Med. 2006; 29(4):363-70. PMID: 17044386; PMCID: PMC1864855.
    85. McDonald C, Carter GT, Abresch RT, Widman L, Styne DM, Warden N, Kilmer DD. Body composition and water compartment measurements in boys with Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2005 Jul; 84(7):483-91. PMID: 15973084.
      View in: PubMed
    86. Jensen MP, Abresch RT, Carter GT, McDonald C. Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil. 2005 Jun; 86(6):1155-63. PMID: 15954054.
      View in: PubMed
    87. McDonald C, Widman LM, Walsh DD, Walsh SA, Abresch RT. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil. 2005 Apr; 86(4):802-8. PMID: 15827935.
      View in: PubMed
    88. McDonald C, Widman L, Abresch RT, Walsh SA, Walsh DD. Utility of a step activity monitor for the measurement of daily ambulatory activity in children. Arch Phys Med Rehabil. 2005 Apr; 86(4):793-801. PMID: 15827934.
      View in: PubMed
    89. McGinnis KB, Vogel LC, McDonald C, Porth S, Hickey KJ, Davis M, Bush P, Jenkins D. Recognition and management of autonomic dysreflexia in pediatric spinal cord injury. J Spinal Cord Med. 2004; 27 Suppl 1:S61-74. PMID: 15503705.
      View in: PubMed
    90. Liusuwan A, Widman L, Abresch RT, McDonald C. Altered body composition affects resting energy expenditure and interpretation of body mass index in children with spinal cord injury. J Spinal Cord Med. 2004; 27 Suppl 1:S24-8. PMID: 15503699.
      View in: PubMed
    91. McDonald C. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil. 2002 Nov; 81(11 Suppl):S108-20. PMID: 12409816.
      View in: PubMed